Hinge Health (HNGE) Current Deferred Revenue (2023 - 2026)

Hinge Health has disclosed Current Deferred Revenue across 4 years of filings, most recently posting $340.8 million for Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $340.8 million, up 56.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $340.8 million (up 56.8% YoY), and the FY2025 annual result was $300.9 million, up 38.24% from the prior year.
• Current Deferred Revenue came in at $340.8 million for Q1 2026 at Hinge Health, up from $300.9 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $340.8 million in Q1 2026 to a low of $140.5 million in Q4 2023.
• The 4-year median for Current Deferred Revenue is $217.6 million (2024), against an average of $243.3 million.
• Across the five-year window, Current Deferred Revenue jumped 38.24% in 2025 and surged 56.8% in 2026, its largest moves.
• Hinge Health's Current Deferred Revenue stood at $140.5 million in 2023, then soared by 54.93% to $217.6 million in 2024, then surged by 38.24% to $300.9 million in 2025, then grew by 13.27% to $340.8 million in 2026.
• The last three Current Deferred Revenue figures came in at $340.8 million (Q1 2026), $300.9 million (Q4 2025), and $299.7 million (Q3 2025), per Business Quant data.